NHS Resolution has supplied the following information:<\/p>
<\/p>
NHS Resolution holds information relating to claims notified to it against pre-defined injury, cause and specialty codes. NHS Resolution has used the following search terms:<\/p>
<\/p>
The total number of clinical claims where one of the injuries was \u2018stroke\u2019 and one of the causes was \u2018Failure/Delay Diagnosis\u2019 or \u2018Wrong Diagnosis\u2019, received 1 December 2016 to 30 November 2017 was 35.<\/p>
<\/p>
NHS Resolution does not have a code for mistreatment of atrial fibrillation so it has undertaken a search of the number of clinical claims where one of the injuries was \u2018stroke\u2019 and \u2018atrial fibrillation\u2019 was mentioned in the incident details reported, received 1 December 2016 to 30 November 2017.<\/p>
<\/p>
NHS Resolution has advised that it cannot provide the number of claims because to do so might lead to the identification of an individual.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1542", "label" : {"_value" : "Biography information for Philip Dunne"} } , "answeringMemberConstituency" : {"_value" : "Ludlow"} , "answeringMemberPrinted" : {"_value" : "Mr Philip Dunne"} , "dateOfAnswer" : {"_value" : "2017-12-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-12-21T15:41:10.17Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-12-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Negligence"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, how many clinical negligence claims relating to a stroke have been made against NHS trusts due to (a) a misdiagnosis and (b) mistreatment of atrial fibrillation in the last twelve months.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"} } , "tablingMemberConstituency" : {"_value" : "Huddersfield"} , "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"} ], "uin" : "119277"} , {"_about" : "http://data.parliament.uk/resources/790113", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/790113/answer", "answerText" : {"_value" : "
The Government made £150 million of additional investment available in the 2014 Autumn Statement for children and young people\u2019s eating disorder services (including services for anorexia), over the five years to 2019/20. From April 2017, we established a new eating disorder service waiting time for children and young people \u2013 with the ambition that by 2020/21 95% of children will receive treatment within one week for urgent cases and within four weeks for routine cases.<\/p>
<\/p>
The latest data from NHS England showed that in Q1 2017-18 73.3% of patients started urgent treatment within one week and 78.7% of patients started routine treatment within four weeks.<\/p>
<\/p>
NHS England has now commissioned 70 new or enhanced community services for eating disorders so everyone can get the help they need to manage these conditions. The National Collaborating Centre for Mental Health in partnership with the National Institute for Health and Care Excellence (NICE) is developing a pathway for adults with eating disorders, together with detailed implementation guidance for providers, during 2017/18. The pathway will be fully informed by the available evidence and the views of experts.<\/p>
<\/p>
NICE also published its updated Clinical Guideline: Eating Disorders \u2013 recognition and treatment, on managing and treating eating disorders for the over 8s - including adults, children and young people in May 2017.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-11-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-11-23T12:32:44.717Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-11-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Anorexia"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to ensure that people with anorexia have access to timely treatment and early intervention.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"} } , "tablingMemberConstituency" : {"_value" : "Huddersfield"} , "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"} ], "uin" : "113381"} , {"_about" : "http://data.parliament.uk/resources/788547", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/788547/answer", "answerText" : {"_value" : "
The Autism Act was made and given Royal Assent on 12 November 2009.<\/p>
<\/p>
The Act places three key duties on the Secretary of State for Health:<\/p>
<\/p>
- To produce a strategy for meeting the needs of adults in England with autistic spectrum conditions (the Strategy), and to keep the Strategy under review;<\/p>
- To produce Statutory Guidance for local councils and local health bodies on implementing the Strategy which they have a duty to act in accordance with; and<\/p>
- To keep the Statutory Guidance under review, considering, in particular, the extent to which the guidance has been effective in securing the implementation of the strategy.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-11-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-11-21T13:41:17.67Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-11-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Autism"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will bring forward legislative proposals on autism.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"} } , "tablingMemberConstituency" : {"_value" : "Huddersfield"} , "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"} ], "uin" : "112643"} , {"_about" : "http://data.parliament.uk/resources/786397", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/786397/answer", "answerText" : {"_value" : "
There are no circumstances in which sodium chlorite or bleach, or these other substances, should be used as a treatment for autism.<\/p>
<\/p>
We have been clear that these compounds have no proven or conceivable health benefit and may cause serious damage to health.<\/p>
<\/p>
The Food Standards Agency has issued advice on sodium chlorite to local authorities to take appropriate action and placed consumer advice for oral products on its website.<\/p>
<\/p>
Local authorities have responsibility for preventing the sale of these products through retail outlets under trading standards legislation.<\/p>
<\/p>
Where there is any threat to the safety and wellbeing of a child, this may lead to offences of child cruelty being considered, requiring a wider safeguarding response involving the police, children's services and relevant partners. Such a threat could include any harm caused by the administration of a potentially noxious substance.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-11-16", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "112049"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-11-16T13:34:59.85Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-11-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Chlorine Dioxide"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps his Department has taken to prohibit the promotion, sale and use of MMS chlorine dioxide bleach as a cure for autism.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"} } , "tablingMemberConstituency" : {"_value" : "Huddersfield"} , "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"} ], "uin" : "112048"} , {"_about" : "http://data.parliament.uk/resources/786398", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/786398/answer", "answerText" : {"_value" : "
There are no circumstances in which sodium chlorite or bleach, or these other substances, should be used as a treatment for autism.<\/p>
<\/p>
We have been clear that these compounds have no proven or conceivable health benefit and may cause serious damage to health.<\/p>
<\/p>
The Food Standards Agency has issued advice on sodium chlorite to local authorities to take appropriate action and placed consumer advice for oral products on its website.<\/p>
<\/p>
Local authorities have responsibility for preventing the sale of these products through retail outlets under trading standards legislation.<\/p>
<\/p>
Where there is any threat to the safety and wellbeing of a child, this may lead to offences of child cruelty being considered, requiring a wider safeguarding response involving the police, children's services and relevant partners. Such a threat could include any harm caused by the administration of a potentially noxious substance.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-11-16", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "112048"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-11-16T13:34:59.913Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-11-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Autism: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to prohibit the promotion, sale and use of Turpentine, GcMAF and Rerum as treatments for autism.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"} } , "tablingMemberConstituency" : {"_value" : "Huddersfield"} , "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"} ], "uin" : "112049"} , {"_about" : "http://data.parliament.uk/resources/777660", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/777660/answer", "answerText" : {"_value" : "
NHS England commissions specialist renal services for adults, children and young people and has recently published renal service specifications (that cover dialysis, acute kidney injury, renal assessment and transplantation) that should lead to uniform high levels of kidney care across England. Further information can be found via the following link:<\/p>